0
Your cart

Your cart is empty

Books > Medicine > Other branches of medicine > Psychiatry

Buy Now

Anxiolytics (Hardcover, 2000 ed.) Loot Price: R2,896
Discovery Miles 28 960
Anxiolytics (Hardcover, 2000 ed.): Mike Briley, David Nutt

Anxiolytics (Hardcover, 2000 ed.)

Mike Briley, David Nutt

Series: Milestones in Drug Therapy

 (sign in to rate)
Loot Price R2,896 Discovery Miles 28 960 | Repayment Terms: R271 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

For over thirty years the benzodiazepines monopolised not only the anxiolytic market but also clinical and animal research in anxiety. Indeed many animal tests developed since the 1960s have been optimised for the benzodiazepines and some programmes have even screened candidates as potential anxiolytics on their benzodiazepine-like side-effects rather than their anxiolytic activity. With the realisation of the drawbacks of the benzodiazepines, namely their potential for tolerance and dependency, there has been a renewed interest in alternative anxiolytics both from existing drugs such as the tricyclic and monoamine oxidase antidepressants and from newer agents such as buspirone. In addition anxiety is no longer considered to be a unique entity but rather an umbrella term for a series of specific anxiety disorders such as panic disorder without or with agoraphobia, generalised anxiety disorder (GAD), specific phobias, social phobias and post-traumatic stress disorder (PTSD). These new clinical categories have opened another dimension in the therapy of anxiety requiring the optimisation of treatments for different syndromes. This book is a critical review of today's anxiolytics and those that may become the anxiolytics of tomorrow. What is clear is that currently there are few clinically satisfactory alternatives to the benzodiazepines for the treatment of acute anxiety. For chronic anxiety, it is generally agreed that benzodi azepines are not the treatment of first choice. The tricyclic and monoamine oxidase antidepressants, the serotonin reuptake inhibitors and buspirone offer better solutions for chronic anxiety but they are still far from being ideal."

General

Imprint: Birkhauser Verlag AG
Country of origin: Switzerland
Series: Milestones in Drug Therapy
Release date: September 2000
First published: 2000
Editors: Mike Briley • David Nutt
Dimensions: 235 x 155 x 12mm (L x W x T)
Format: Hardcover
Pages: 181
Edition: 2000 ed.
ISBN-13: 978-3-7643-6032-0
Categories: Books > Medicine > Other branches of medicine > Psychiatry
Books > Medicine > General issues > Medical equipment & techniques > Medical research
Books > Medicine > Other branches of medicine > Pharmacology > General
LSN: 3-7643-6032-1
Barcode: 9783764360320

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners